On Tuesday, June 27, 2017, California Senate Bill 790 will be heard in the Assembly Committee on Health, with limited testimony allowed per side. We have previously written about the bill, noting that the bill passed the California Senate back in May 2017.
The bill, if passed as written, would prohibit a manufacturer of a prescribed product from offering or giving a gift to a health care provider. The bill would further prohibit a manufacturer of a prescribed product or an entity on behalf of a manufacturer of a prescribed product from providing a fee, payment, subsidy, or other economic benefit to a health care provider in connection with the provider’s participation in research, except as specified.
Under existing Sunshine Act law, manufacturers are required to disclose to the Centers for Medicare and Medicaid Services (CMS) any payments or other transfers of value made to physicians or teaching hospitals.
The intent of the Legislature is that the prohibitions and requirements described above will operate in conjunction with the Sunshine Act. If the Sunshine Act is repealed or becomes inoperative, the intent of the Legislature to enact legislation similar to the Sunshine Act.
To read the article by Thomas Sullivan
